Trial · NCT05315557
Efficacy and Safety of Vasopressin Versus Terlipressin as a Second Vasopressor in Critically Ill Cirrhotics With Septic Shock- the VITEL-C Trial
NCT05315557, Not applicable, Unknown, Institute of Liver and Biliary Sciences, India
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Efficacy and Safety of Vasopressin Versus Terlipressin as a Second Vasopressor in Critically Ill Cirrhotics With Septic Shock- the VITEL-C Trial. Trials, record NCT05315557. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05315557
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Efficacy and Safety of Vasopressin Versus Terlipressin as a Second Vasopressor in Critically Ill Cirrhotics With Septic Shock- the VITEL-C Trial
- NCT number
- NCT05315557
- Status
- Unknown
- Phases
- Not applicable
- Enrollment
- 100 participants, estimated
- Lead sponsor
- Institute of Liver and Biliary Sciences, India
- Conditions
- Septic Shock, Cirrhosis, Liver
- Interventions
- Terlipressin, vasopressin
- First posted
- 2022-04-07
- Last updated
- 2022-04-07
Source ClinicalTrials.gov
Registered outcomes31
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Improvement in systemic hemodynamics at 6 hours after randomization | 6 hours after randomization | Improvement in systemic hemodynamics defined as discontinuation of noradrenaline infusion OR reversal of shock |
| Secondary | Reduction in dose of noradrenaline at the end of 6 hours | 6 hours | |
| Secondary | Amount of noradrenaline requirements between in each arm at the end of 6 hours | 6 hours | |
| Secondary | Improvement in Systemic Vascular Resistance (SVR) by 10% or above 500 at 6 hours | 6 hours | Systemic Vascular Resistance will be measured by using pulmonary thermodilution |
| Secondary | Improvement in SVR by 10% or above 500 at 12 hours | 12 hours | |
| Secondary | Improvement in SVR by 10% or above 500 at 48 hours | 48 hours | |
| Secondary | Decrease in Cardiac output by 10% or less than 6L after 6 hours of randomization | 6 hour of randomization | Cardiac output will be measured by using pulmonary thermodilution |
| Secondary | KDIGO criteria - increase in urine output in 6 hours | 6 hour | |
| Secondary | KDIGO criteria - increase in urine output in 12 hours. | 12 hour | |
| Secondary | KDIGO criteria - increase in urine output in 24 hours | 24 hour |
1 to 10 of 31Source ClinicalTrials.gov
See all 31 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05315557
GET https://conductscience.org/api/trials/v1/NCT05315557/registered?page=2